Prosecution Insights
Last updated: November 18, 2026

Rikarbon Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Rikarbon Inc. has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, Colman Thomas Welles, who holds 1 pending action. The portfolio's current activity is restricted to 1 distinct art unit, indicating a singular point of contact for the company's pending matters at the USPTO.

The presence of Colman Thomas Welles as the only examiner indicates that the company's current patent activity is concentrated. Practitioners should note that with only 1 pending office action, there is no internal data to compare examiner performance or art unit trends within this portfolio. This focus means that the outcome of this specific matter will define the company's current success rate in the Biotechnology & Pharmaceuticals sector. The ratio of pending office actions to distinct examiners stands at 1 to 1. Because the workload is limited to 1 distinct art unit, the company's strategy is tied to the specific examination practices of that unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WELLES, COLMAN THOMAS 1 25.9% +66.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18033583 RENEWABLE OILS: COMPOSITION, PROCESS OF MAKING AND FORMULATION WELLES, COLMAN THOMAS 35d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18033583 RENEWABLE OILS: COMPOSITION, PROCESS OF MAKING AND FORMULATION WELLES, COLMAN THOMAS 35d overdue

Top Art Units

Art UnitApps
1612 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18033583 RENEWABLE OILS: COMPOSITION, PROCESS OF MAKING AND FORMULATION WELLES, COLMAN THOMAS 1612 §102§103§112DP Final Rejection 35d overdue Pending Apr 25, 2023

Managing Rikarbon Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Rikarbon Inc. have?

Rikarbon Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Rikarbon Inc. applications?

Colman Thomas Welles has the most, with 1 of Rikarbon Inc.'s pending office actions.

What technology area are Rikarbon Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month